Key Developments: Pain Therapeutics Inc (PTIE.O)

PTIE.O on Nasdaq

31 Mar 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

Pfizer to discontinue agreement on REMOXY extended-release capsules CII with Pain Therapeutics, Inc
Monday, 27 Oct 2014 08:00am EDT 

Pfizer Inc:To discontinue its agreement to develop and commercialize REMOXY (oxycodone) Extended-Release Capsules CII, an investigational extended-release oral formulation of oxycodone.To return all rights, including responsibility for regulatory activities, to Pain Therapeutics, Inc.  Full Article


Pfizer ends deal with Pain Therapeutics to develop Durect's pain drug

- Pfizer Inc ended an agreement with Pain Therapeutics Inc to develop and market Durect Corp's pain drug, Remoxy, sending the stocks of the two smaller drugmakers plummeting.

Search Stocks